FineMark National Bank & Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.47M | Sell |
179,519
-355
| -0.2% | -$8.95K | 0.14% | 127 |
|
|
2025
Q3 | $4.58M | Sell |
179,874
-4,615
| -3% | -$114K | 0.15% | 122 |
|
|
2025
Q2 | $4.47M | Sell |
184,489
-1,493
| -0.8% | -$34.8K | 0.15% | 121 |
|
|
2025
Q1 | $4.71M | Sell |
185,982
-10,604
| -5% | -$277K | 0.17% | 117 |
|
|
2024
Q4 | $5.22M | Sell |
196,586
-15,412
| -7% | -$418K | 0.18% | 109 |
|
|
2024
Q3 | $6.14M | Sell |
211,998
-4,969
| -2% | -$145K | 0.21% | 102 |
|
|
2024
Q2 | $6.07M | Sell |
216,967
-35,475
| -14% | -$977K | 0.22% | 102 |
|
|
2024
Q1 | $7.01M | Sell |
252,442
-19,017
| -7% | -$528K | 0.26% | 90 |
|
|
2023
Q4 | $7.82M | Sell |
271,459
-18,858
| -6% | -$570K | 0.32% | 81 |
|
|
2023
Q3 | $9.63M | Sell |
290,317
-17,835
| -6% | -$631K | 0.42% | 69 |
|
|
2023
Q2 | $11.3M | Sell |
308,152
-196
| -0.1% | -$7.63K | 0.46% | 55 |
|
|
2023
Q1 | $12.6M | Buy |
308,348
+484
| +0.2% | +$20.9K | 0.54% | 49 |
|
|
2022
Q4 | $15.8M | Sell |
307,864
-20,338
| -6% | -$975K | 0.71% | 36 |
|
|
2022
Q3 | $14.4M | Sell |
328,202
-5,910
| -2% | -$287K | 0.69% | 31 |
|
|
2022
Q2 | $17.5M | Sell |
334,112
-5,774
| -2% | -$294K | 0.77% | 27 |
|
|
2022
Q1 | $17.6M | Sell |
339,886
-87,760
| -21% | -$4.55M | 0.7% | 30 |
|
|
2021
Q4 | $25.3M | Sell |
427,646
-1,013
| -0.2% | -$50.2K | 0.96% | 18 |
|
|
2021
Q3 | $18.4M | Sell |
428,659
-1,865
| -0.4% | -$82.6K | 0.78% | 24 |
|
|
2021
Q2 | $16.9M | Sell |
430,524
-838
| -0.2% | -$32.6K | 0.69% | 29 |
|
|
2021
Q1 | $15.6M | Sell |
431,362
-2,003
| -0.5% | -$71.1K | 0.66% | 31 |
|
|
2020
Q4 | $16M | Sell |
433,365
-30,517
| -7% | -$1.12M | 0.71% | 27 |
|
|
2020
Q3 | $16.2M | Sell |
463,882
-545
| -0.1% | -$19.1K | 0.78% | 25 |
|
|
2020
Q2 | $14.4M | Buy |
464,427
+2,714
| +0.6% | +$92.2K | 0.8% | 27 |
|
|
2020
Q1 | $14.3M | Buy |
461,713
+7,145
| +2% | +$243K | 0.9% | 24 |
|
|
2019
Q4 | $16.9M | Buy |
454,568
+10,082
| +2% | +$359K | 0.85% | 23 |
|
|
2019
Q3 | $15.2M | Buy |
444,486
+1,204
| +0.3% | +$43.8K | 0.81% | 25 |
|
|
2019
Q2 | $18.2M | Buy |
443,282
+15,066
| +4% | +$598K | 1.01% | 16 |
|
|
2019
Q1 | $17.3M | Sell |
428,216
-11,753
| -3% | -$471K | 1% | 15 |
|
|
2018
Q4 | $18.2M | Buy |
439,969
+5,554
| +1% | +$231K | 1.24% | 10 |
|
|
2018
Q3 | $18.2M | Sell |
434,415
-15,228
| -3% | -$586K | 1.11% | 12 |
|
|
2018
Q2 | $15.5M | Buy |
449,643
+10,582
| +2% | +$362K | 0.94% | 16 |
|
|
2018
Q1 | $14.8M | Buy |
439,061
+6,359
| +1% | +$219K | 0.94% | 19 |
|
|
2017
Q4 | $14.9M | Buy |
432,702
+6,789
| +2% | +$231K | 0.94% | 16 |
|
|
2017
Q3 | $14.4M | Sell |
425,913
-5,304
| -1% | -$170K | 0.96% | 15 |
|
|
2017
Q2 | $13.7M | Buy |
431,217
+9,208
| +2% | +$290K | 0.99% | 13 |
|
|
2017
Q1 | $13.7M | Buy |
422,009
+3,342
| +0.8% | +$105K | 1% | 13 |
|
|
2016
Q4 | $12.9M | Buy |
418,667
+5,279
| +1% | +$161K | 1.03% | 12 |
|
|
2016
Q3 | $13.3M | Buy |
413,388
+19,074
| +5% | +$638K | 1.42% | 11 |
|
|
2016
Q2 | $13.2M | Buy |
394,314
+18,325
| +5% | +$585K | 1.47% | 11 |
|
|
2016
Q1 | $10.6M | Buy |
375,989
+9,240
| +3% | +$264K | 1.24% | 12 |
|
|
2015
Q4 | $11.2M | Buy |
366,749
+28,909
| +9% | +$909K | 1.34% | 11 |
|
|
2015
Q3 | $10.1M | Buy |
337,840
+19,393
| +6% | +$622K | 1.36% | 9 |
|
|
2015
Q2 | $10.1M | Buy |
318,447
+3,293
| +1% | +$107K | 1.32% | 10 |
|
|
2015
Q1 | $10.4M | Buy |
315,154
+15,169
| +5% | +$482K | 1.42% | 9 |
|
|
2014
Q4 | $8.87M | Buy |
299,985
+12,416
| +4% | +$356K | 1.3% | 11 |
|
|
2014
Q3 | $8.07M | Buy |
287,569
+14,189
| +5% | +$398K | 1.29% | 8 |
|
|
2014
Q2 | $7.7M | Buy |
273,380
+4,976
| +2% | +$142K | 1.3% | 10 |
|
|
2014
Q1 | $8.18M | Buy |
268,404
+10,688
| +4% | +$319K | 1.53% | 9 |
|
|
2013
Q4 | $7.49M | Buy |
257,716
+16,290
| +7% | +$474K | 1.55% | 8 |
|
|
2013
Q3 | $6.58M | Buy |
241,426
+8,258
| +4% | +$225K | 1.63% | 8 |
|
|
2013
Q2 | $6.2M | Buy |
+233,168
| New | +$6.44M | 1.86% | 8 |
|
Other funds holding PFE
FineMark National Bank & Trust's PFE Position: Q4 2025 in Review
FineMark National Bank & Trust reduced its Pfizer (PFE) stake by 0.2% in Q4 2025, selling an estimated $8.95K and leaving 179,519 shares worth $4.47M. The position accounts for 0.14% of the portfolio, ranked #127.
FineMark National Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $25.3M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- FineMark National Bank & Trust held 179,519 shares of Pfizer worth $4.47M as of Q4 2025.
- FineMark National Bank & Trust sold 355 Pfizer shares in Q4 2025, an estimated $8.95K.
- Pfizer made up 0.14% of FineMark National Bank & Trust's portfolio in Q4 2025, its #127 holding.
- FineMark National Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- FineMark National Bank & Trust's Pfizer position peaked at $25.3M in Q4 2021.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.